Catch up on the most well-viewed prostate imaging content from 2023.
As we come to the end of 2023, we take a look back at the most well-read prostate imaging content with topics ranging from emerging PSMA PET radiotracers to prostate artery embolization for men with an enlarged prostate. Review the slideshow below to see highlighted prostate imaging content from the past year.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Study: PSMA PET/CT More Advantageous than MRI for Locoregional Staging of Prostate Cancer
July 8th 2024For men with prostate cancer, new research demonstrates that 18F-PSMA-1007 PET/CT is 17 percent more accurate than mpMRI at identifying the final pathological tumor stage and 12 percent more accurate in detecting extracapsular extension.
Could MRI-Based AI Offer Better Risk Stratification for Prostate Cancer than PI-RADS?
July 3rd 2024The combination of deep learning assessment of prostate MRI with PI-RADS classification at a 15 percent risk threshold spared 49 percent of biopsies in comparison to 37 percent employing a PI-RADS>4 only cut-ff approach, according to new research.